Seamus Lagan, COO of Medytox noted, “The acquisition of ClinLab fits perfectly within the objectives of our strategic growth plan. We are excited about the integration of ClinLab’s technology to enhance our capabilities and services to our customers".
Chicago, IL (PRWEB) April 03, 2014
ClinLab, Inc. provides leading healthcare information management systems to medical clinics, hospitals, public health departments and other medical practices. The company offers a complete instrument technology interface package for effective laboratory automation from billing by procedure to automatic data transfer. ClinLab’s web-enabled technology provides interfaces to the most popular hospital information systems and group practice management systems enabling more efficient and accurate data management. The company’s innovative technology allows secure remote access features allowing multi-location access and remote printing.
Medytox Solutions, Inc. develops and delivers cutting-edge testing and reporting technology systems to medical laboratories throughout North America. Medytox offers a complete, turn-key urine drug testing (UDT) program allowing physicians to proactively monitor and treat patients. In addition to toxicology and clinical testing, Medytox provides new and innovative testing options such as oral fluid testing, dry fluid testing and neurotransmitter testing among others. In 2012, testing services to rehabilitation facilities represented over 70% of gross revenues. Medytox is headquartered in West Palm Beach, Florida. The details of the transaction were undisclosed.
Seamus Lagan, COO of Medytox Solutions, Inc. noted, “The acquisition of ClinLab Inc fits perfectly within the objectives of our strategic growth plan. We are excited about the integration of ClinLab’s technology to enhance our capabilities and services to our customers.”
About Pegasus Intellectual Capital Solutions
PegasusICS is a Chicago based investment bank that advises and assists companies on capital raising, mergers and acquisitions – including cross-border – exit planning, restructuring and workout, and shareholder value maximization. PegasusICS operates across North America as well as internationally. The partners of PegasusICS have consummated over three billion dollars in transactions with a former client base ranging from leading lower middle market enterprises to Fortune 100 companies.
PegasusICS is a leader in healthcare, food and beverage, agriculture, manufacturing, technology and extractive energy investment banking services. Pegasus Intellectual Capital Solutions was named "2013 Investment Banking Boutique of the Year" by Acquisition Finance Magazine, "Investment Banking Boutique of the Year 2013 – USA" by Intercontinental Finance Magazine, and selected for the distinction of "Top 200 Investment Banks and Boutiques" by American Registry. On March 24, 2014 PegasusICS was named "Agribusiness Sector M&A Advisory Firm of the Year - USA" by Corporate Intl Magazine.
For more information, visit http://www.PegasusICS.com